In honor of Carolyn Bertozzi's recent Nobel Prize win, we're re-releasing this episode, originally recorded in 2020, featuring her discussing her research on developing a new type of drug that can target specific disease-related proteins for degradation by the cell.
Nov 24
The Future of Healthcare Payments: CMS Chief of Staff Stephanie Carlton
<p>A labor and delivery nurse who ran Senate healthcare policy now manages $1.7 trillion in federal health spending—and she runs her team like a startup.</p><p>Steph Carlton, Chief of Staff and Deputy Administrator at CMS, reveals the OKRs driving Medicare and Medicaid, why they' ... Show More
26m 53s
Nov 17
How to Build This Generation's Big Pharma Company
<p>Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. </p><p>In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma compa ... Show More
41m 4s
Dec 2023
Cat parasite Toxoplasma tricked to grow in a dish
In this episode:00:48 A new way to grow a tricky parasite in the labToxoplasma gondii, the parasite that causes the zoonotic disease toxoplasmosis, has a complex, multi-stage life cycle. Some of these stages will only grow in the intestines of cats, making it difficult to study. ... Show More
25m 48s
Jun 2022
Improve Your Metabolism, Reduce Disease, and Increase Health Span Through Protein Restriction with Tracy Anthony
<p>Dr Tracy Anthony is a world-class scientist, Professor of Nutritional Sciences at Rutgers University, and expert on cellular responses to nutrition and exercise. She uses animal models to explore mechanisms of proteostasis. This lesser-known proteostasis network is directly ti ... Show More
1h 19m